Indication
Doxorubicin-induced cardiomyopathy
3 clinical trials
3 products
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer PatientsStatus: Recruiting, Estimated PCD: 2025-01-31
Product
DH001Clinical trial
Clinical Study to Evaluate the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Product
DapagliflozinClinical trial
Role of Statin Therapy in Prevention of Anthracycline-Induced CardiotoxicityStatus: Recruiting, Estimated PCD: 2023-06-01
Product
Atorvastatin